{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:42:59Z","timestamp":1792665779887,"version":"4.5.0"},"reference-count":42,"publisher":"MyJove Corporation","issue":"139","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/57231","type":"journal-article","created":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T20:00:25Z","timestamp":1536609625000},"source":"Crossref","is-referenced-by-count":1,"title":["A Rabbit Model of Durable Transgene Expression in Jugular Vein to Common Carotid Artery Interposition Grafts"],"prefix":"10.3791","author":[{"given":"Lianxiang","family":"Bi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley K.","family":"Wacker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Dichek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2018,9,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1161\/CIRCRESAHA.116.308334","type":"journal-article","article-title":"Atherosclerosis: Successes, Surprises, and Future Challenges","volume":"118","author":"Libby","year":"2016","unstructured":"Libby, P., Bornfeldt, K. E., & Tall, A. R. Atherosclerosis: Successes, Surprises, and Future Challenges. Circ Res. 118 531-534 (2016).","journal-title":"Circ Res"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","type":"journal-article","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","unstructured":"Fowkes, F. G. et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 382 1329-1340 (2013).","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(13)60141-5","type":"journal-article","article-title":"Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial","volume":"381","author":"Mohr","year":"2013","unstructured":"Mohr, F. W. et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet. 381 629-638 (2013).","journal-title":"Lancet"},{"issue":"8","key":"ref4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nrcardio.2016.76","type":"journal-article","article-title":"Vein graft failure: from pathophysiology to clinical outcomes","volume":"13","author":"de Vries","year":"2016","unstructured":"Vries, M. R., Simons, K. H., Jukema, J. W., Braun, J., & Quax, P. H. Vein graft failure: from pathophysiology to clinical outcomes. Nat Rev Cardiol. 13 (8), 451-470 (2016).","journal-title":"Nat Rev Cardiol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/SLA.0b013e318288c38d","type":"journal-article","article-title":"Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions","volume":"257","author":"Harskamp","year":"2013","unstructured":"Harskamp, R. E., Lopes, R. D., Baisden, C. E., de Winter, R. J., & Alexander, J. H. Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions. Ann Surg. 257 824-833 (2013).","journal-title":"Ann Surg"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/CIRCULATIONAHA.111.039842","type":"journal-article","article-title":"Understanding saphenous vein graft patency","volume":"124","author":"Sabik","year":"2011","unstructured":"Sabik, J. F., 3rd. Understanding saphenous vein graft patency. Circulation. 124 (3), 273-275 (2011).","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/1358863X07083432","type":"journal-article","article-title":"Lower extremity vein graft failure: a translational approach","volume":"13","author":"Owens","year":"2008","unstructured":"Owens, C. D., Ho, K. J., & Conte, M. S. Lower extremity vein graft failure: a translational approach. Vasc Med. 13 63-74 (2008).","journal-title":"Vasc Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pharmthera.2012.07.002","type":"journal-article","article-title":"Prevention of coronary in-stent restenosis and vein graft failure: does vascular gene therapy have a role","volume":"136","author":"Robertson","year":"2012","unstructured":"Robertson, K. E., McDonald, R. A., Oldroyd, K. G., Nicklin, S. A., & Baker, A. H. Prevention of coronary in-stent restenosis and vein graft failure: does vascular gene therapy have a role? Pharmacol Ther. 136 23-34 (2012).","journal-title":"Pharmacol Ther"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.ymthe.2017.03.027","type":"journal-article","article-title":"Cardiovascular Gene Therapy: Past, Present, and Future","volume":"25","author":"Yla-Herttuala","year":"2017","unstructured":"Yla-Herttuala, S., & Baker, A. H. Cardiovascular Gene Therapy: Past, Present, and Future. Mol Ther. 25 1095-1106 (2017).","journal-title":"Mol Ther"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S0741-5214(99)70215-6","type":"journal-article","article-title":"Adenoviral-mediated gene transfer of a constitutively active form of the retinoblastoma gene product attenuates neointimal thickening in experimental vein grafts","author":"Schwartz","year":"1999","unstructured":"Schwartz, L. B. et al. Adenoviral-mediated gene transfer of a constitutively active form of the retinoblastoma gene product attenuates neointimal thickening in experimental vein grafts. J Vasc Surg. (5), 874-881 (1999).","journal-title":"J Vasc Surg"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jvs.2009.03.027","type":"journal-article","article-title":"Local lentiviral short hairpin RNA silencing of CCR2 inhibits vein graft thickening in hypercholesterolemic apolipoprotein E3-Leiden mice","volume":"50","author":"Eefting","year":"2009","unstructured":"Eefting, D. et al. Local lentiviral short hairpin RNA silencing of CCR2 inhibits vein graft thickening in hypercholesterolemic apolipoprotein E3-Leiden mice. J Vasc Surg. 50 152-160 (2009).","journal-title":"J Vasc Surg"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.jvs.2008.07.029","type":"journal-article","article-title":"Adventitial delivery of platelet-derived endothelial cell growth factor gene prevented intimal hyperplasia of vein graft","volume":"48","author":"Handa","year":"2008","unstructured":"Handa, M. et al. Adventitial delivery of platelet-derived endothelial cell growth factor gene prevented intimal hyperplasia of vein graft. J Vasc Surg. 48 (6), 1566-1574 (2008).","journal-title":"J Vasc Surg"},{"key":"ref13","first-page":"31","type":"journal-article","article-title":"Adenoviral activin A expression prevents vein graft intimal hyperplasia in a rat model","volume":"8","author":"Kloppenburg","year":"2009","unstructured":"Kloppenburg, G. T., Grauls, G. E., Bruggeman, C. A., & Stassen, F. R. Adenoviral activin A expression prevents vein graft intimal hyperplasia in a rat model. Interact Cardiov Th. 8 31-34 (2009).","journal-title":"Interact Cardiov Th"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/cvr\/cvq203","type":"journal-article","article-title":"A novel urokinase receptor-targeted inhibitor for plasmin and matrix metalloproteinases suppresses vein graft disease","volume":"88","author":"Eefting","year":"2010","unstructured":"Eefting, D. et al. A novel urokinase receptor-targeted inhibitor for plasmin and matrix metalloproteinases suppresses vein graft disease. Cardiovasc Res. 88 367-375 (2010).","journal-title":"Cardiovasc Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jss.2008.12.012","type":"journal-article","article-title":"Gene transfer of COX-1 improves lumen size and blood flow in carotid bypass grafts","volume":"161","author":"Eichstaedt","year":"2010","unstructured":"Eichstaedt, H. C. et al. Gene transfer of COX-1 improves lumen size and blood flow in carotid bypass grafts. J Surg Res. 161 162-167 (2010).","journal-title":"J Surg Res"},{"issue":"11","key":"ref16","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1038\/mt.2008.188","type":"journal-article","article-title":"In vivo modulation of Nogo-B attenuates neointima formation","volume":"16","author":"Kritz","year":"2008","unstructured":"Kritz, A. B. et al. In vivo modulation of Nogo-B attenuates neointima formation. Mol Ther. 16 (11), 1798-1804 (2008).","journal-title":"Mol Ther"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejvs.2010.04.013","type":"journal-article","article-title":"The role of ex-vivo gene therapy of vein grafts with Egr-1 decoy in the suppression of intimal hyperplasia","volume":"40","author":"Peroulis","year":"2010","unstructured":"Peroulis, M. et al. The role of ex-vivo gene therapy of vein grafts with Egr-1 decoy in the suppression of intimal hyperplasia. Eur J Vasc Endovasc. 40 216-223 (2010).","journal-title":"Eur J Vasc Endovasc"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1073\/pnas.93.12.5731","type":"journal-article","article-title":"A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and b-galactosidase","volume":"93","author":"Kochanek","year":"1996","unstructured":"Kochanek, S. et al. A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and b-galactosidase. Proc Natl Acad Sci U S A. 93 5731-5736 (1996).","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"13565","DOI":"10.1073\/pnas.93.24.13565","type":"journal-article","article-title":"A helper-dependent adenovirus vector system: Removal of helper virus by Cre-mediated excision of the viral packaging signal","volume":"93","author":"Parks","year":"1996","unstructured":"Parks, R. J. et al. A helper-dependent adenovirus vector system: Removal of helper virus by Cre-mediated excision of the viral packaging signal. P Natl Acad Sci USA. 93 13565-13570 (1996).","journal-title":"P Natl Acad Sci USA"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1073\/pnas.94.5.1645","type":"journal-article","article-title":"Persistence in muscle of an adenoviral vector that lacks all viral genes","volume":"94","author":"Chen","year":"1997","unstructured":"Chen, H.-H. et al. Persistence in muscle of an adenoviral vector that lacks all viral genes. P Natl Acad Sci USA. 94 1645-1650 (1997).","journal-title":"P Natl Acad Sci USA"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1161\/01.CIR.0000141574.78032.A9","type":"journal-article","article-title":"Improved vascular gene transfer with a helper-dependent adenoviral vector","volume":"110","author":"Wen","year":"2004","unstructured":"Wen, S., Graf, S., Massey, P. G., & Dichek, D. A. Improved vascular gene transfer with a helper-dependent adenoviral vector. Circulation. 110 1484-1491 (2004).","journal-title":"Circulation"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/hum.2014.084","type":"journal-article","article-title":"Efficient gene transfer and durable transgene expression in grafted rabbit veins","volume":"26","author":"Du","year":"2015","unstructured":"Du, L., Zhang, J., Clowes, A. W., & Dichek, D. A. Efficient gene transfer and durable transgene expression in grafted rabbit veins. Hum Gene Ther. 26 47-58 (2015).","journal-title":"Hum Gene Ther"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0008-6363(97)00098-9","type":"journal-article","article-title":"Efficient adenoviral gene transfer to early venous bypass grafts: comparison with native vessels","volume":"35","author":"Channon","year":"1997","unstructured":"Channon, K. M. et al. Efficient adenoviral gene transfer to early venous bypass grafts: comparison with native vessels. Cardiovasc Res. 35 505-513, (1997).","journal-title":"Cardiovasc Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/mt.2011.133","type":"journal-article","article-title":"Expression of apolipoprotein A-I in rabbit carotid endothelium protects against atherosclerosis","volume":"19","author":"Flynn","year":"2011","unstructured":"Flynn, R. et al. Expression of apolipoprotein A-I in rabbit carotid endothelium protects against atherosclerosis. Mol Ther. 19 1833-1841 (2011).","journal-title":"Mol Ther"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/CIRCULATIONAHA.110.012732","type":"journal-article","article-title":"Sustained Reduction of Vein Graft Neointima Formation by Ex Vivo TIMP-3 Gene Therapy","volume":"124","author":"George","year":"2011","unstructured":"George, S. J. et al. Sustained Reduction of Vein Graft Neointima Formation by Ex Vivo TIMP-3 Gene Therapy. Circulation. 124 (11 Suppl), S135-142 (2011).","journal-title":"Circulation"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0003-4975(02)03831-6","type":"journal-article","article-title":"Gene transfer to coronary artery bypass conduits","volume":"74","author":"Chiu-Pinheiro","year":"2002","unstructured":"Chiu-Pinheiro, C. K. et al. Gene transfer to coronary artery bypass conduits. Ann Thorac Surg. 74 1161-1166 (2002).","journal-title":"Ann Thorac Surg"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jvs.2009.10.080","type":"journal-article","article-title":"Animal models for the assessment of novel vascular conduits","volume":"52","author":"Byrom","year":"2010","unstructured":"Byrom, M. J., Bannon, P. G., White, G. H., & Ng, M. K. Animal models for the assessment of novel vascular conduits. J Vasc Surg. 52 176-195 (2010).","journal-title":"J Vasc Surg"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jacc.2007.03.031","type":"journal-article","article-title":"Effects of oral prednisone after stenting in a rabbit model of established atherosclerosis","volume":"50","author":"Ribichini","year":"2007","unstructured":"Ribichini, F. et al. Effects of oral prednisone after stenting in a rabbit model of established atherosclerosis. J Am Coll Cardiol. 50 176-185 (2007).","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"ref29","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1055\/s-2005-858055","type":"journal-article","article-title":"Quantification of in-stent restenosis parameters in rabbits by Micro-CT","volume":"177","author":"Langheinrich","year":"2005","unstructured":"Langheinrich, A. C. et al. Quantification of in-stent restenosis parameters in rabbits by Micro-CT. Rofo. 177 (4), 501-506 (2005).","journal-title":"Rofo"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1161\/ATVBAHA.116.308258","type":"journal-article","article-title":"Local Vascular Gene Therapy With Apolipoprotein A-I to Promote Regression of Atherosclerosis","volume":"37","author":"Wacker","year":"2017","unstructured":"Wacker, B. K., Dronadula, N., Zhang, J., & Dichek, D. A. Local Vascular Gene Therapy With Apolipoprotein A-I to Promote Regression of Atherosclerosis. Arterioscler Thromb. 37 316-327 (2017).","journal-title":"Arterioscler Thromb"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1161\/01.ATV.9.3.374","type":"journal-article","article-title":"Atherosclerosis in rabbit vein grafts","volume":"9","author":"Zwolak","year":"1989","unstructured":"Zwolak, R. M., Kirkman, T. R., & Clowes, A. W. Atherosclerosis in rabbit vein grafts. Arteriosclerosis. 9 374-379 (1989).","journal-title":"Arteriosclerosis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.atherosclerosis.2012.03.013","type":"journal-article","article-title":"Statin therapy prevents expansive remodeling in venous bypass grafts","volume":"223","author":"Qiang","year":"2012","unstructured":"Qiang, B. et al. Statin therapy prevents expansive remodeling in venous bypass grafts. Atherosclerosis. 223 106-113 (2012).","journal-title":"Atherosclerosis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev-bioeng-071516-044539","type":"journal-article","article-title":"Thrombus Formation at High Shear Rates","volume":"19","author":"Casa","year":"2017","unstructured":"Casa, L. D. C., & Ku, D. N. Thrombus Formation at High Shear Rates. Annu Rev Biomed Eng. 19 415-433 (2017).","journal-title":"Annu Rev Biomed Eng"},{"issue":"2","key":"ref34","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/096721099700500205","type":"journal-article","article-title":"Reduced blood flow accelerates intimal hyperplasia in endarterectomized canine arteries","volume":"5","author":"Chen","year":"1997","unstructured":"Chen, C., Coyle, K. A., Hughes, J. D., Lumsden, A. B., & Ku, D. N. Reduced blood flow accelerates intimal hyperplasia in endarterectomized canine arteries. Cardiovasc Surg. 5 (2), 161-168 (1997).","journal-title":"Cardiovasc Surg"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/0741-5214(89)90449-7","type":"journal-article","article-title":"Optimal graft diameter: effect of wall shear stress on vascular healing","volume":"10","author":"Binns","year":"1989","unstructured":"Binns, R. L., Ku, D. N., Stewart, M. T., Ansley, J. P., & Coyle, K. A. Optimal graft diameter: effect of wall shear stress on vascular healing. J Vasc Surg. 10 326-337 (1989).","journal-title":"J Vasc Surg"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/gt.2014.85","type":"journal-article","article-title":"Gene therapy for rhesus monkeys heterozygous for LDL receptor deficiency by balloon catheter hepatic delivery of helper-dependent adenoviral vector","volume":"22","author":"Oka","year":"2015","unstructured":"Oka, K., Mullins, C. E., Kushwaha, R. S., Leen, A. M., & Chan, L. Gene therapy for rhesus monkeys heterozygous for LDL receptor deficiency by balloon catheter hepatic delivery of helper-dependent adenoviral vector. Gene Ther. 22 87-95 (2015).","journal-title":"Gene Ther"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/CIRCINTERVENTIONS.114.001522","type":"journal-article","article-title":"Prevention of neointimal formation after angioplasty using nuclear factor-kappaB decoy oligodeoxynucleotide-coated balloon catheter in rabbit model","volume":"7","author":"Miyake","year":"2014","unstructured":"Miyake, T. et al. Prevention of neointimal formation after angioplasty using nuclear factor-kappaB decoy oligodeoxynucleotide-coated balloon catheter in rabbit model. Circ Cardiovasc Interv. 7 787-796 (2014).","journal-title":"Circ Cardiovasc Interv"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1096\/fj.12-224659","type":"journal-article","article-title":"Site-specific gene delivery to stented arteries using magnetically guided zinc oleate-based nanoparticles loaded with adenoviral vectors","volume":"27","author":"Chorny","year":"2013","unstructured":"Chorny, M. et al. Site-specific gene delivery to stented arteries using magnetically guided zinc oleate-based nanoparticles loaded with adenoviral vectors. FASEB J. 27 2198-2206 (2013).","journal-title":"FASEB J"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/sj.gt.3302793","type":"journal-article","article-title":"Three catheter-based strategies for cardiac delivery of therapeutic gelatin microspheres","volume":"13","author":"Hoshino","year":"2006","unstructured":"Hoshino, K. et al. Three catheter-based strategies for cardiac delivery of therapeutic gelatin microspheres. Gene Ther. 13 1320-1327 (2006).","journal-title":"Gene Ther"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"5557","DOI":"10.2147\/IJN.S140734","type":"journal-article","article-title":"Preparation, characterization, and transfection efficiency of low molecular weight polyethylenimine-based nanoparticles for delivery of the plasmid encoding CD200 gene","author":"Nouri","year":"2017","unstructured":"Nouri, F., Sadeghpour, H., Heidari, R., & Dehshahri, A. Preparation, characterization, and transfection efficiency of low molecular weight polyethylenimine-based nanoparticles for delivery of the plasmid encoding CD200 gene. Int J Nanomed. 5557-5569 (2017).","journal-title":"Int J Nanomed"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/sj.cgt.7700432","type":"journal-article","article-title":"Eradication of osteosarcoma lung metastases following intranasal interleukin-12 gene therapy using a nonviral polyethylenimine vector","author":"Jia","year":"2002","unstructured":"Jia, S. F. et al. Eradication of osteosarcoma lung metastases following intranasal interleukin-12 gene therapy using a nonviral polyethylenimine vector. Cancer Gene Ther. 260-266 (2002).","journal-title":"Cancer Gene Ther"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1172\/JCI117123","type":"journal-article","article-title":"Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides","volume":"93","author":"Morishita","year":"1994","unstructured":"Morishita, R. et al. Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. J Clin Invest. 93 1458-1464 (1994).","journal-title":"J Clin Invest"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jove.com\/video\/57231\/a-rabbit-model-durable-transgene-expression-jugular-vein-to-common","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:31:29Z","timestamp":1792665089000},"score":1,"resource":{"primary":{"URL":"https:\/\/app.jove.com\/t\/57231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,10]]},"references-count":42,"journal-issue":{"issue":"139","published-online":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.3791\/57231","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,10]]}}}